Examines specific targets and the cognate drugs
Evaluates molecular modes of innate and evolving resistance
eBook - ePub
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
About this book
Comprehensively covers the multiplicity and diversity of mechanisms underlying resistance to the currently approved drugs, both tyrosine kinase inhibitors and monoclonal antibodies, that specifically inhibit growth factor receptors playing driver or survival functions in cancer
Table of contents
- Cover
- Front Matter
- 1.Ā Resistance of Colorectal Tumors to Anti-EGFR Antibodies
- 2.Ā Resistance of Lung Cancer to Kinase Inhibitors Specific to EGFR or ALK
- 3.Ā Mechanisms of Action and Resistance of Trastuzumab in Breast Cancer
- 4.Ā Mechanisms of Resistance to Molecular Therapies Targeting the HGF/MET Axis
- 5.Ā RAF, MEK and ERK Inhibitors as Anti-Cancer Drugs: Intrinsic and Acquired Resistance as a Major Therapeutic Challenge
- 6.Ā Mechanisms of Resistance to PI3K and AKT Inhibitors
- 7.Ā Sensitivity and Resistance to BH3 Mimetics in Cancer Therapy
- 8.Ā Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors
- 9.Ā Resistance to Inhibitors of Angiogenesis
- Back Matter
Trusted byĀ 375,005 students
Access to over 1.5 million titles for a fair monthly price.
Study more efficiently using our study tools.
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn how to download books offline
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.5M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1.5 million books across 990+ topics, weāve got you covered! Learn about our mission
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more about Read Aloud
Yes! You can use the Perlego app on both iOS and Android devices to read anytime, anywhere ā even offline. Perfect for commutes or when youāre on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app
Yes, you can access Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways by Yosef Yarden,Moshe Elkabets in PDF and/or ePUB format, as well as other popular books in Medicine & Oncology. We have over 1.5 million books available in our catalogue for you to explore.